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Abstract The relatively rapid growth of the direct-to-
consumer (DTC) genetic testing market in the last few
years has led to increasing attention from both the scientific
community and policy makers. One voice often missing in
these debates, however, is that of the actual user of these
genetic testing services. In order to gain a better picture of
the motivations and expectations that propel individuals to
purchase DTC genome-wide testing, we conducted an
exploratory study based on users’ personal stories. Through
qualitative content analysis of users’ personal stories found
on Internet blogs and DTC genetic testing companies’
websites, we identified five major sets of motivations and
expectations towards DTC genome-wide testing. These
themes are related to (1) health, (2) curiosity and
fascination, (3) genealogy, (4) contributing to research,
and (5) recreation. Obtaining such information can help us
to understand how users consider genome-wide testing and
forms the basis for further research.
Introduction
New genomic knowledge is shifting the focus from testing
for specific and rare monogenic diseases to genetic and
genomic testing to predict the risk of developing common
complex diseases. The current advances provide the hope to
develop new methods in prediction, prevention, diagnosis,
and treatment of diseases and of achieving better health in
general (Khoury 2003). The translation of genomic medi-
cine is an essential goal for the medical and public health
community; however, the effective transfer of emerging
genomic knowledge and applications into clinical settings
is a long process which has to overcome many barriers.
Elaborating on the results of genome-wide association
studies, some private companies have been advertising and
selling genetic tests directly to consumers (Hunter et al.
2008). As a consequence, consumers can now obtain
genetic tests without any involvement from a health care
professional. The companies selling these services argue
that obtaining genetic information can help individuals to
construct their identity (by ancestry testing) or promote
their health (by changing their habits after having received
disease risk predictions). According to these companies,
after receiving personal risk predictions based on genetic
information, consumers will be able to use the test results in
their daily life, particularly in monitoring or improving their
health conditions (Foster et al. 2006). Autonomy, empow-
erment, prevention, convenience, and privacy are the
principle keywords in the marketing of these direct-to-
consumer (DTC) genetic tests (Howard and Borry 2009).
The rapid growth of the DTC genetic testing market has
led to increasing attention from both the scientific commu-
nity and policy makers. Different types of genetic tests sold
directly to consumers (i.e., carrier testing versus testing for
common complex diseases or single-gene testing versus
testing for hundreds of different loci) raise different specific
scientific, ethical, legal, and social concerns; however, a
general list of some of the important concerns regarding the
field in general can be outlined. Concerns have been raised
Y. Su (*) :H. C. Howard : P. Borry
Centre for Biomedical Ethics and Law,
Katholieke Universiteit Leuven,
Kapucijnenovoer 35, Box 7001, 3000 Leuven, Belgium
e-mail: suyeyang@yahoo.com.cn
P. Borry
Department of Clinical Genetics and Department of Medical
Humanities, EMGO Institute for Health and Care Research,
VU University Medical Center,




about the scientific accuracy, clinical validity, and clinical
utility of DTC genetic tests, especially for common
complex traits (Janssens et al. 2008; Mihaescu et al. 2009;
Foster et al. 2009). Concerns were also raised with regard
to the absence and/or quality of the pre- and posttest genetic
counseling (Wade and Wilfond 2006), as well as with the
absence of individualized medical supervision (Hogarth et
al. 2008). The lack of an adequate consent procedure as
well as the inappropriate genetic testing of minors has also
been criticized (Borry et al. 2009a, b). Further concerns
include the research activities of DTC genetic testing
companies (Howard et al. 2010), the (lack of) respect for
privacy, and the potential burden on public health resources
(McGuire et al. 2009).
Various professional organizations and governmental
agencies have published their statements to inform, educate,
and/or warn consumers about DTC genetic testing (Amer-
ican College of Obstetricians and Gynaecologists 2008;
Federal Trade Commission 2009; Human Genetics Com-
mission 2010; United States Government Accountability
Office 2006; United States Government Accountability
Office 2010; Nuffield Council on Bioethics 2010). Along
these lines, the European Society of Human Genetics
endorsed in August 2010 a statement which included,
among others, recommendations to ensure the quality of the
testing services, the provision of pretest information and
genetic counseling, a face to face consultation, and
oversight of this industry (European Society of Human
Genetics 2010). Moreover, since the spring of 2010, the
US Food and Drug Administration has decided to
investigate more closely the market activities of DTC
genetic testing companies, which may impact on the
future regulatory oversight of the DTC genetic testing
market (Allison 2010).
At the present time, little information is known about the
motivation of users to purchase DTC genetic tests.
McGowan and colleagues (McGowan et al. 2010) pub-
lished the results of a qualitative study in which they
interviewed 23 early users (those who purchased tests
“within the first two years of their availability on the
market”) of personal genome services. To date, this is the
only full-length publication providing firsthand accounts of
DTC genetic testing (GT) users’ reasons for purchasing
DTC personal genome services. When asked about the
main reasons for purchasing personal genome services, the
interviewees most frequently answered that they did so to:
(1) “gain health-related information” and (2) “learn about
individual risk factors.” Additional motivation factors
included wanting to be at the “vanguard of adopting and
testing the capabilities of new technologies” and having a
professional interest in the service (McGowan et al. 2010).
Kaufman and colleagues also presented the results of an
online survey of 1,048 customers of three direct-to-
consumer personal genomic testing companies at the
American Society of Human Genetics 60th Annual Meeting
(2010). (Kaufman et al. 2010). Although the full article has
yet to be published, the abstract reveals that the top three
reasons for customers to purchase DTC genetic testing were
identified as (1) satisfying curiosity, (2) learning about
elevated risks of diseases, and (3) learning about ancestry
(Kaufman et al. 2010). Other studies have looked at the
attitudes of members of the general public regarding genetic
testing and the provision of these tests directly to consum-
ers (Wilde et al. 2010). One study (McGuire et al. 2009)
surveyed the general public via facebook to find out,
among others, about their use and interest in genetic testing,
as well as their attitudes towards DTC genetic testing
companies. Yet, other studies created circumstances that
were similar to the DTC genetic testing context, but that
were still different in a number of ways. Bloss et al. (2010)
recruited mainly employees from a number of health and
technology companies and invited them to take part in a
study whereby participants were offered genome-wide
testing from a DTC genetic testing company at a signifi-
cantly discounted rate compared with what individuals in
the general public would have to pay. They reported
primarily on demographic characteristics of the participants
as well as concerns participants had regarding being
involved in the project and obtaining results for an
unpreventable disease (Bloss et al. 2010). Meanwhile,
through the Multiplex initiative, McBride et al. (2009) tried
to evaluate what psychological and behavioral factors
predict who is likely to seek SNP-based genetic tests for
multiple common health conditions. In addition, a form of
personal case study has also been published by at least two
academics and one journalist who purchased DTC genetic
testing. Richards (2010) published an account of his
experience in a peer-reviewed journal, and Collins and
Duncan each discussed their experiences as a part of full-
length books (Collins 2010; Duncan 2009).
Other than the studies conducted by McGowan et al.
(2010) and Kaufman et al. (2010), the abovementioned
studies provide information about a type of public
concerning genetics and/or genomic testing but were not
focused on an actual population of users of DTC GT.
Herein, we specifically wanted to obtain information
from individuals who have already purchased genome-
wide testing sold by a DTC genetic testing company.
Our goal was to explore their motivations for purchas-
ing these tests and to further understand their expect-
ations of these services. To do so, we collected and
analyzed (via Internet postings) users’ personal stories





Genome-wide testing: For the purposes of this study, the
term genome-wide testing (GWT) is used to mean the
testing of hundreds of thousands to millions of genetic
markers (often single nucleotide variants (SNPs)) throughout
the genome. Terms such as “full genome testing” (Howard et
al. 2010), “personal genome scanning” (McGowan et al.
2010), or “personal genomic testing” (Cherkas et al. 2010)
have also been used to denote this type of testing.
Companies selling DTC GWT typically return personalized
risk estimates/profiles for multiple health conditions, and/or
for pharmacogenomic information, and non-health related
traits (i.e., eye color, hair type); some companies also return
genealogical information. Companies that offer GWT are a
subset of DTC genetic testing companies. That is to say that
not all DTC GT companies sell GWT; some companies only
analyze one or a few genetic variations.
User or customer: The focus population of this study are
individuals who have already purchased and used a
genome-wide test from a DTC GT company. In order to
distinguish an actual user of a genetic test from a general
consumer who may or may not purchase a genetic test, we
use the terms “user” and “customer” to denote the former.
Data collection
The personal stories of customers who purchased DTC GWT
for themselves and/or for their families were collected for this
study. The aim was to find stories of actual users explaining
their motivations and expectations for having purchased DTC
GWT. Such stories were found on non-company websites as
well as on DTC GWT companies’ websites (which post
customer stories). Non-blog mass media news items, in which
reporters discussed their (or other customers’) experiences
related to DTC genetic testing, were excluded from this study.
Moreover, due to the complex methodological issues raised
by the analysis of images (Silverman 2006), video segments
(e.g., Youtube) were also excluded.
Customer stories were collected via the Internet search
engine Google. Five companies which provide DTC
genome-wide testing services were selected as targeted
companies in this research: 23andMe, deCODE (service
called deCODEme), Navigenics, Seqwright, and Biomarker
Pharmaceutical (service called Gene Essence). As a search
strategy, the keywords “My DNA result” + “company
name” or “service name” were used in Google search
during the time period from February 17 to 20, 2010. As
this study was aimed to be an explorative study, not all
stories found were analyzed; a convenient sample of 120
stories was selected for preliminary analysis. Of the stories
obtained in this way, only stories written in English and in
which users addressed their reasons to purchase the test
and/or expectations of the tests were kept for content analysis.
Data analysis
Stories were analyzed using content analysis. Words,
sentences, and paragraphs that described customers’
expectations or motivations were collected in the prelim-
inary analysis to develop codes. At the early stage of
analysis, the original words from these stories were used
as code labels, and a preliminary coding taxonomy was
generated during the investigation. A second review of
the stories and the coding taxonomy helped to create
advanced categories to conceptualize customers’ detailed
expectations and motivations towards DTC genetic




Of the 120 stories obtained for preliminary analysis, 56 stories
were written in English and addressed DTC GWT users’
expectations and motivations for purchasing tests. These 56
stories were, therefore, retained for content analysis. Twenty-
nine (52%) stories were published on DTC GWT companies'
websites (often in the form of an interview), and 27 (48%)
stories were found on non-company websites (usually in the
form of a first-person blog).
Based on the personal information provided by custom-
ers in their stories, it would appear that the 56 stories
studied were posted by 47 different individuals; five
customers blogged more than once about their experience
(on non-company websites), and each blog story was
counted as a different story. Furthermore, due to the fact
that some customers purchased more than one test from
more than one company, the 56 stories represent the
purchasing of 60 genome-wide tests from three different
companies. No customer stories describing motivations and
expectations were found in which Gene Essence or SeqWright
are mentioned. The majority of users in our study purchased
genome-wide tests from 23andMe (57%; 34/60), 30% (18/60)
of tests were purchased from deCODE (deCODEme), and
13% (8/60) from Navigenics. Both 23andMe and deCODE
offer, among others, health-related results and ancestry or
genealogy information, while Navigenics only offers
health-related results. The 56 stories studied were published
between December 2007 and January 2010; all stories were
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first accessed in February 2010 and verified again in
September 2010.
Some educational and/or professional information could
be retrieved for 38 of the 47 customers: 8 are trained in
genetics or medicine, 15 are businessmen, entrepreneurs,
attorneys, or engineers, and 15 are journalists or profes-
sional bloggers. Nineteen out of 47 customers identified
themselves as parents, and considered taking the test not
only for themselves but also for their families.
Themes and subthemes
Based on our analysis, users of DTC GWT expressed five
predominant sets of motivations and expectations towards
DTC genome-wide testing (Table 1). These themes are
related to (1) health, (2) curiosity and fascination, (3)
genealogy, (4) contributing to research, and (5) recreation.
Some quotes from customers are relevant for more than one
(sub)theme. Due to the possibility that themes obtained
from stories on company websites could differ from themes
found in stories obtained on non-company websites, we
evaluated both groups separately as well as together. We
found that stories from both origins express the same
themes. However, in stories found on company websites,
the most cited reason by far to purchase DTC GWT is
health-related. Meanwhile, in stories from non-company
websites, the most important reasons to purchase tests were
curiosity and genealogy.
Theme 1: health-related motivations and expectations
Overall, the foremost reason to purchase DTC GWT is
associated with health-related motivations and expectations.
However, as stated above, this theme was much more
predominant in stories from company websites, while it was
much less important in stories found on non-company
websites.
Subtheme 1.1: to address concerns for specific diseases
Some customers expressed their concerns for a specific
disease as a motivation to purchase DTC GWT. They often
referred to the fact that “this” disease runs in the family.
Various customers expressed that they want to know their
own risk for developing that specific disease.
I chose to take the deCODEme complete scan because
I also wanted to learn about my genetic predisposition
for developing age-related macular degeneration
(AMD). My grandmother developed AMD in her
mid 70s and, for years, I have wondered if I would
one day be among the 40% of Canadians over the age
of 75 to develop AMD. (source: company website,
Anna Peterson, deCODEme: http://www.decodeme.
com/customer-stories/the-gift-of-knowledge-genetics-
and-prevention, accessed 24 September 2010)
The genetic osteoporosis problem was a major
reason why I decided to get a DNA SNP scan. (source:
non-company website, Jerry Emanuelson, deCODEme
and 23andMe: http://www.futurescience.com/dna/je-
comments.html, accessed 24 September 2010)
“One of the reasons that I was so interested in having
genetic testing is my family history. Having someone in
your life with Alzheimer’s is a really tough thing. Being
able to find information about my genetic risk factors
that would allow me to take an active role in managing
my health was very appealing to me.” (source: company
website, Jim, Navigenics: http://www.navigenics.com/
visitor/what_we_offer/success_stories/jim/, accessed
24 September 2010)
Subtheme 1.2: to improve the quality of health and to live
longer Some users expressed the belief that their genetic
risk information would empower them to make positive
future healthcare decisions, improve their health, and allow
them to live a longer life.
Table 1 Overview of themes and subthemes obtained from customers’ stories regarding direct-to-consumer genome-wide testing
Theme 1: health-related motivations and expectationsa
Subtheme 1.1: to address concerns for certain diseases
Subtheme 1.2: to improve the quality of health and to live longer
Subtheme 1.3: to learn about medical history
Theme 2: motivations and expectations related to curiosity and fascinationb
Subtheme 2.1: curiosity and fascination about the technology
Subtheme 2.2: curiosity and fascination about genetic information generated and learning about genetics/genomics
Theme 3: genealogy-related motivations and expectationsb
Theme 4: motivations and expectations related to participation in or contributing to research
Theme 5: recreation-related (non-genealogy) motivations and expectations
a the predominant theme obtained from customer stories found on company websites
b the predominant themes obtained from customer stories found on non-company websites
J Community Genet
Personally I think having more information about
myself can only be a good thing. Because you
can act on it. A gene coding for a prostate cancer
predisposition isn’t a death sentence—it’s a call to
action. Eat better, get exercise, get checked every
year after you’re 40. That sort of thing. (source:
non-company website, Nat Friedman, 23andMe:
http://nat.org/blog/2008/02/personal-genetics/,
accessed 24 September 2010)
“By learning about my genetic predisposition for
different illnesses, I will be better prepared to take an
active role in my future health care decisions.”
(source: company website, Anna Peterson, deCO-
DEme: http://www.decodeme.com/customer-stories/
the-gift-of-knowledge-genetics-and-prevention,
accessed 24 September 2010)
“I almost feel evangelical about my health,” says the 62-
year-old businessman from Spokane, Washington.
“I’m so excited about what can happen if you do the
right things and have the right tools.” (source: company
website, Jack Doughery, deCODEme: http://www.
decodeme.com/customer-stories/genetic-test-is-
sensible-self-investment, accessed 24 September 2010)
“I wanted to participate in Navigenics' service,
because I was interested to see what I could learn
about my health. I wanted to know what conditions I
might be predisposed for in the future, so that I could
take steps to protect myself.” (source: company
website, Jackie, Navigenics: http://www.navigenics.
com/visitor/what_we_offer/success_stories/jackie/,
accessed 24 September 2010)
In parallel with the previous subtheme, some customer
stories from company websites expressed the motiva-
tion to learn about potential health risks for their
children.
And at a more practical level, I want to give my
kids as much information as possible about the
cocktail they are inheriting from my husband and
me, so they can better manage their health. (source:
company website, Kim Scott, 23andMe: https://
www.23andme.com/pregnancy/profile/KimScott/,
accessed 24 September 2010)
Maybe learning about my own genetic make-up will
give me the information I need to keep my children
healthy, help them grow. (source: company website,
Nancy Rabinowitz-Friedman, 23andMe:
https://www.23andme.com/pregnancy/thread/708/,
accessed 24 September 2010)
“I wanted to know my risks for my daughter’s sake.
She shares my genes. She comes from me. So I’m
interested to see what her risks are. If they are
increased because of me. It could save her life,”




Subtheme 1.3: to learn about medical history Some
customers expressed the wish to obtain information
about their medical history through DTC GWT. They
considered this a way to substitute for their missing
medical history and obtain medical information that was
not provided to them by family members (e.g., because
of adoption).
For me, it’s deeply personal. I don’t have a medical
history. I can’t tell you who my ancestors were. I was
adopted…I’ve never really understood what doctors
mean by that final “I see,” but I think it means, “Good
luck with the crap shoot that is your medical history.”
So I’ve taken the test. I’ve sent my saliva to California to
determine what’s inside me. (source: non-company
website, Jay Mueller, 23andMe: http://www.3aw.com.
au/blogs/3aw-breakfast-blog/jays-dna-blog/20081209-
6up0.html, accessed 24 September 2010)
Also, because my father is a pathological and
absent liar, I thought it would be cool to learn a
bit about what diseases or conditions I might be
pre-disposed to. Certainly, I can’t depend on
anything he has told me. (source: non-company
website, Wendie Tobin, 23andMe: http://mommytopia.
com/2009/01/13/23andme-sucks-ok/, accessed 24
September 2010)
In the health and medical world, the knowledge base
has grown so much since my parents died. My dad
has been gone since 1992 and my mom died in 2000.
My siblings and I don't have our parents, so being
able to spit into a cup and find some of the answers to
our family health history is a blessing and a
tremendous opportunity. (source: company website,
Michelle Lamar, 23andMe: https://www.23andme.
com/pregnancy/thread/714/, accessed 15 January
2011)
Moreover, on company websites, some users expressed
the value of sharing this family history information with
their relatives in order to provide them with information
about their health.
“I was adopted, so I don’t have any specific
information about my family history. None of that
information is available to me. That has always
concerned me.”(…) “Now I can give my daughter
information about her own health. It’s so thrilling –
for both of us – to go through the Navigenics testing
and see my results. Suddenly we have so much more
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information than most people have about their genetic
make-up.” (source: companywebsite, Terry, Navigencis:
http://www.navigenics.com/visitor/what_we_offer/
success_stories/terry/, accessed 24 September 2010)
The more we know about our family history, the more
we know about ourselves. I spat and became part of
the 23 and Me community because I want to know
more about my ancestors, so I can help myself and
my family live longer, healthier lives. (source:
company website, Michelle Lamar, 23andMe:
https://www.23andme.com/pregnancy/thread/714/,
accessed 24 September 2010)
Theme 2: motivations and expectations related to curiosity
and fascination
Various users expressed a fascination for genetics/genomics
science and for the technology or information offered
through DTC GWT (that is not based specifically on
obtaining health or genealogy information). This was the
predominant theme encountered in blogs found on non-
company websites.
Subtheme 2.1: curiosity and fascination about the technology
Like many early adopters, my interest in sequencing
my genome is driven more by intellectual curiosity
than by pressing health reasons. So I'm hoping that
George Church gets his Personal Genome Project
geared up quickly. I've registered to participate.
(source: non-company website, Gary Wolf, 23andMe:
http://www.kk.org/quantifiedself/2008/01/-like-other-
early-23andme.php, accessed 24 September 2010)
It will be interesting to see how useful this is. I’m
fascinated with genetics, and when whole genome
sequencing becomes affordable, I’ll definitely do that.
The technology is moving quickly. (source: non-
company website, Mark Fletcher, 23andMe: http://
wingedpig.com/2007/12/06/23andme-unboxing/,
accessed 24 September 2010)
We are curious consumers and enjoy the chance to
learn a little more about ourselves no matter how
young and immature the personal genomics space is.
(source: non-company website, Andrew Meyer,
23andMe: http://buzzyeah.com/2008/04/24/how-
heart-attack-and-other-four-star-rated-topics-relate-to-
my-dna-part-2/, accessed 24 September 2010)
“I just think it’s interesting to see what the results are.
To me it’s fantastic deCODE can do it.” (source:
company website, Cheryl Click, deCODEme: http://
www.decodeme.com/customer-stories/the-genetic-
lottery, accessed 24 September 2010)
For some, this fascination is related to their professional
backgrounds and interests.
My work involves building new computer programs
that can help doctors and patients collect, track,
understand, and use family health history and genet-
ic/genomic information in patient care. Therefore I
felt it made perfect sense that I should explore how
technology – both gene chips (or DNA microarrays)
and the Internet – could combine to give me access as
never before to my own biology. (source: non-
company website, Grant Wood, 23andMe: http://
exploringmygenes.blogspot.com/2009/04/influences-
on-my-decision.html, accessed 24 September 2010)
So why did I finally decide to go through with it? One
reason is that I get a lot of questions from people at
the Ask a Geneticist site about how useful or good the
test is. Right now I have to tell them I don't know. I'd
like to be more helpful than that. (source: non-
company website, Barry Starr, 23andMe: http://
www.kqed.org/quest/blog/2009/07/20/taking-the-
plunge-diving-into-my-dna/, accessed 24 September
2010; according to the blog, Dr. Barry Starr is a
Geneticist-in-Residence at The Tech Museum of
Innovation in San Jose, CA and runs their Stanford
at The Tech program.)
Some customers purchased tests because they expect this
is the way medicine will evolve in the future.
I am a bit on the fence about this since it may just give
me more to worry about but I also believe that this is the
future of medicine. (source: non-company website,
Avram Miller, Navigenics: http://twothirdsdone.com/
2007/12/, accessed 24 September 2010)
“We hear a lot of different – and sometimes
conflicting – opinions about how to take care of your
heath. I’m very excited about a future in which I can
receive only the most relevant information to me,
based on my DNA. With these tests there will be an
amazing amount of much smarter and more effective
treatments. There are so many things that medicine
can do better if they know enough about you to really
target what they are doing.” (source: company
website: Aaron, Navigenics: http://www.navigenics.
com/visitor/what_we_offer/success_stories/aaron/,
accessed 24 September 2010)
“I believe it is the way of the future. Even ten years
ago, who would have thought that we would have
all the advances we have today? People are often
scared of things just because they’re new. It’s about
how we educate people and how we make them
feel about it. They need to feel comfortable with
it.” (source: company website, Pam Ayers, deCODEme:
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http://www.decodeme.com/customer-stories/dna-test-
perfect-christmas-present, accessed 15 January 2011)
Subtheme 2.2: curiosity and fascination focused on the
genetic information generated and learning about genetics/
genomics Various users expressed a fascination about the
genetic knowledge generated by DTC genetic testing.
I'm fascinated by genetics and am excited to learn
more about what makes me tick. (source: company
website, Cecily Kellogg, 23andMe: https://
www.23andme.com/pregnancy/profile/Cecilyk/,
accessed 24 September 2010)
“Being an engineer, when I found out I could take these
tests through Navigenics and really understand more
about my genetics – I was fascinated and really wanted
to do it.” (source: company website, Aaron, Navigenics:
http://www.navigenics.com/visitor/what_we_offer/
success_stories/aaron/, accessed 24 September 2010)
Being a daily witness to my family's health issues has
made me incredibly curious about genetics and what
traits and medical ailments could possibly be passed on
to my son. (source: company website, Calliopeblogger,
23andMe: https://www.23andme.com/pregnancy/
profile/Calliopeblogger/, accessed 24 September 2010)
Because of our imminent mortality, it is natural for us
to ask whether we will learn something about our
futures from these types of tests. (source: non-
company website, Grant Wood, 23andMe: http://
exploringmygenes.blogspot.com/2009/04/influences-
on-my-decision.html, accessed 24 September 2010)
Some customers expected that the genetic information
could provide insights into their identities and what makes
them unique.
I also think that it will be fascinating to see all of my
bits of DNA. This is the stuff that is a big part of
making me who I am. (source: non-company website,
Barry Starr, 23andMe: http://www.kqed.org/quest/
blog/2009/07/20/taking-the-plunge-diving-into-my-
dna/, accessed 24 September 2010)
Not all of these questions can be answered, but I am
utterly curious about what makes me unique (or the
eternal optimist, yet neurotic at times)? (source:
company website, Jill Asher, 23andMe: https://
www.23andme.com/pregnancy/thread/718/, accessed
24 September 2010)
So I do want to know as much about myself as I can.
But more than that, I want to know about how I came
to be who I am. (source: company website, Nancy
Rab inowi t z -F r i edman , 23andMe : h t t p s : / /
www.23andme.com/pregnancy/thread/708/, accessed
24 September 2010)
Theme 3: genealogy-related motivations and expectations
Various customers expressed an interest in tracing ancestors
and were interested in knowing where they come from.
Some held an interest in genealogy for a long time before
they decided to purchase DTC GWT. These customers
considered DTC GWT as a new technology that could
enhance their understanding of genealogy and help in
tracing their potential relatives.
Like many Americans, I don’t have a clear picture of
my geographically history… It will be fascinating—
and a gift, really—to be able to say with a bit of
clarity, “Well, according to my genome, I’m from…”
(source: company website, Cecily Kellogg, 23andMe:
https://www.23andme.com/pregnancy/thread/698/,
accessed 24 September 2010)
They test autosomal markers for ancestry and health
purposes. This means for your genealogy you can
now match testers who are not on just your Ydna or
your mtDNA lines. You can match people who are
anywhere in your pedigree charts. (source: non-
company website, Emily Aulicino, 23andMe: http://
genealem-geneticgenealogy.blogspot.com/2009/12/
23andme-success-story.html, accessed 24 September
2010)
I admit it. I have no self-discipline when it comes to
genetic genealogy. When deCODEme launched, I had to
be one of the first in line to get tested. (source: non-
companywebsite,Megan Smolenyak Smolenyak, deCO-
DEme: http://www.rootstelevision.com/blogs/megans-
rootsworld/2007/12/a_first_look_at_decodeme_dna_
r.html, accessed 24 September 2010)
Theme 4: motivations and expectations related
to participation in or contributing to research
Various users expressed an interest to donate their samples
for future research.
“23andMe Sponsored Research: We will analyze your
genetic and other voluntarily contributed personal
information as part of our scientific research with the
purpose of advancing the field of genetics and human
health.” I think many service customers will see this
as a bonus. We want to volunteer, as it makes us feel
we are part of something greater than ourselves.
(source: non-company website, Grant Wood,
23andMe: http://exploringmygenes.blogspot.com/
2009/06/reading-about-consents-risks-and.html,
accessed 24 September 2010)
And the pregnancy community at 23andMe will give
me an opportunity to contribute to future research on
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pregnancy conditions, discomforts and other health
issues. (source: company website, Meagan Francis,
23andMe: https://www.23andme.com/pregnancy/
thread/710/, accessed 24 September 2010)
Or even that I may help someone else by contributing
to research that could lead to breakthroughs in any
number of medical fields. (source: company website,
Nancy Rabinowitz-Friedman, 23andMe: https://
www.23andme.com/pregnancy/thread/708/, accessed
24 September 2010)
Theme 5: recreation-related (non-genealogy-related)
motivations and expectations
Various customers are interested in DTC GWT for
recreational purposes other than formal genealogy. In
particular, some users humorously expressed an interest in
finding out if they could be related to someone famous. Of
course, this was never stated as the main reason for
purchasing a test, but it was mentioned as an “added
bonus.”
Also, I'm hoping I'll find out that I'm distantly related
to George Clooney - and that he'll want to meet me
and then maybe we'll become friends, and then he'll
fall madly in love with me and.... (source: company
website, Nancy Rabinowitz-Friedman, 23andMe:
https://www.23andme.com/pregnancy/profile/
NYNancy/, accessed 24 September 2010)
Impressed by Andrew Niccols' prescient (if insuffi-
ciently palindromic) GATTACA I assumed that there
might even be SNPs that would convince Uma
Thurman to have my babies. (source: non-company
website, Myles Axton, deCODEme: http://blogs.nature.
com/ng/freeassociation/2007/12/everything_you_
need_to_last_yo.html, accessed 24 September 2010)
Discussion
The results of this exploratory study show that, overall, the
major motivations and reasons for purchasing DTC GWT,
as expressed by users, are linked to health. The fact that this
theme is pervasive in the stories published on company
websites whereas the stories from non-company websites
express predominantly motivations related to curiosity and
genealogy may suggest that companies are selectively
publishing stories that promote health-related reasons. We
cannot rule out the possibility that this is also partly due to
the health focus of customers who decide to share their
stories with companies. Nonetheless, the overall results are
in line with other studies that have shown that health-
related issues are at the center of individuals’ reasons for
wanting DTC genetic testing. This was reported in the
studies by McGowan et al. (2010) and Kaufman et al.
(2010), which, like our study, were focused on actual users
or customers of DTC personal genome scanning services.
Bloss et al. (2010) also showed that more than 80% of their
study participants, who did purchase DTC GT but at a
reduced price and within the context of a research project,
wanted to know their genetic risk for treatable as well as for
non-preventable disorders. Results from McGuire et al.’s
(2009) survey, which addressed a more general audience of
facebook-using individuals, suggest that of those who have
used a personal genome test, 60% (38/60) consider the
information obtained to be a diagnosis of medical condition
or disease, and 51% used the test “To see if a specific
disease runs in family or is in DNA.” Finally, a recent study
by Cherkas et al. (2010), in which a closed-ended survey
was administered to adult twins participating in the
TwinsUK Adult Twin Registry, showed that of those
respondents who stated some interest in purchasing a
“personal genetic screen,” the most popular reason for
doing so would be to “encourage me to adopt a healthier
lifestyle if found to be at high risk of disease.” Similarly,
a large portion of respondents would obtain such testing
so that their “doctor can monitor my health more
closely.”
The attention to health-related concerns from stories of
users on company websites as well as those found on non-
company websites is of particular interest as most DTC
genetic testing companies have disclaimers on their
websites stating that their services are not meant to be used
as medical advice or as a diagnostic tool. For example,
23andMe states in the terms of service section of their
website “23andMe Service Is For Research and Educational
Use Only. We Do Not Provide Medical Advice, And The
Services Cannot Be Used For Health Ascertainment or
Disease Purposes” (23andMe 2010). Regarding deCODE’s
personal genome testing service (known as deCODEme),
one can find in their service agreement and informed
consent section “The Genetic Scan product is for informa-
tional purposes only, is not medical advice, and is not a
substitute for professional medical advice, genetic counsel-
ing, diagnosis, or treatment” (deCODE 2010). The presence
of these disclaimers is interesting for many reasons
(Howard and Borry 2009), but we point out two principal
issues. Firstly, it appears somewhat contradictory for
companies to be posting these disclaimers and yet have
users’ stories on their websites focus mostly on the health-
related aspects of the tests. Secondly, as all stories analyzed
in our study come from people who have actually
purchased tests, they should have, therefore, seen the
companies’ websites and signed the terms of services or
informed consent forms. With this in mind, it is discon-
J Community Genet
certing to see that some users may have overestimated the
potential value of the tests purchased. Like us, McGowan et
al. (2010) found that the two most common reasons for
purchasing GWT were health related. However, they also
revealed that half of their 23 interviewees “felt that the
results of the scan are not medically actionable,” and few
participants changed their behavior after obtaining the
results of the GWT. Furthermore, similarly to DTC GT
companies, McGowan et al. (2010) distinguish the ideas of
“informational value” from “medical value” stating that
early adopters of GWT attribute a “largely informational
rather than medical value” to this service. This differenti-
ation as well as the distinction between medical information
and health-related information may be meaningful in theory
(especially legally); however, in practice, these demarca-
tions may lose some of their significance.
In addition, it was noticed that some users did express an
expectation of resolving their concerns regarding familial
medical conditions based on the genetic test results.
However, since we focused this study on motivations and
expectations, we did not further analyze these expectations.
(For example, were they realistic expectations? What was
the apparent degree of (mis)understanding of the users
regarding the information provided by the DTC genetic
testing companies, including the test results?) Indeed, the
study of consumer (mis)understanding of information
remains an important aspect that requires further research.
Thus, overall, the information above tends to support the
critiques of DTC genetic testing companies regarding the
notion that consumers may be vulnerable to false or
misleading advertising claims or to claims that tend to
overstate the value of the companies’ services in order to
increase their sales (United States Government Account-
ability Office 2006; United States Government Account-
ability Office 2010). At the base of this problem is
consumer/user understanding; how much do consumers
and users understand about DTC genetic testing in general?
Specifically, to what extent do recipients of GWT-based
risk information understand their results, including the
probabilistic nature of the risk estimates provided? Is there
a risk that consumers may overestimate their value
(McBride et al. 2010)? Some authors have argued that
consumers may lack sufficient health literacy to interpret
the genetic information provided (McBride et al. 2010).
Moreover, Lachance et al. (2010) reported that the average
reading grade level of DTC genetic testing websites is far
above the average reading skill level of adults in the USA.
That being said, McGowan and co-authors (2010) conclud-
ed that the early adopters they interviewed consider GWT
“with both optimism and personal interest…and skepticism
about the genomic technology’s current capabilities.”
(McGowan et al. 2010) Being skeptical, however, does
not imply having a great understanding of the technology or
results thereof, and McGowan and co-authors do not report
having studied users’ outright understanding of GWT.
The potential impact of providing disease risk informa-
tion generated from genomic test results on individual
behavior and future health is also a matter of debate
(Gulcher and Stefansson 2010; Ransohoff and Khoury
2010). There is presently little research regarding how
individual consumers are likely to respond to their results.
It is unclear whether this information could lead users to
make positive health behavior changes, adopt more fatalis-
tic attitudes, or increase/decrease anxiety levels (Bloss et al.
2010). A recent study by Bloss and colleagues (Bloss et al.
2011), however, does shed some light on this issue. They
found no significant changes in anxiety levels, dietary fat
intake, or exercise behavior after uptake of DTC GWT
(from Navigenics Health Compass) in 2,037 research
participants. The large majority of participants did not
exhibit test-related distress, and there was no significant
increase in the use of consequent follow-up screening tests
following the test. Furthermore, little is known on how
consumers might respond to changes in risk predictions and
whether continual updates of risk predictions might change
their perception of risk (Mihaescu et al. 2009). As stated
earlier, however, McGowan et al’s study did reveal that few
early adopters used the information obtained from GWT to
change their health-related behaviors.
The fact that our study focuses on the motivations and
expectations of users means that, by default, we emphasize
their interest in these services. However, it remains unclear
to what extent the public at large is interested in these
services and if the present model of DTC genetic testing is
a sustainable one. In recent months, various DTC compa-
nies have ceased their activities (Borry et al. 2010a). One
genome-wide-testing service we focused on for this study
(which was in service when we started our study) was
offered by Biomarker Pharmaceutical under the product
name Gene Essence; the Gene Essence website with
information regarding a GWT service, however, is no
longer active. Other companies, like DNA Direct, Counsyl,
and Navigenics, have changed their delivery model and
now require consumers to order test via a medical doctor
(Borry et al. 2010b). Foreshadowing these changes, a report
by the investment bank Burril & Company (San Francisco)
revealed that consumers’ attachment to their physicians has
been underestimated and that physicians remain the most
likely source to which individuals will turn for health and
genetic information (Burril & Company/Change Wave
Research 2008). Furthermore, a recent calculation by
Wright and Gregory-Jones (2010) estimates the current
demand for DTC whole genome scans to be relatively
small.
The willingness to participate in research, as expressed
in the users’ personal stories, mirrors the willingness of
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many research volunteers. Numerous studies have indicated
that many people are willing to permit the use of their tissue
and information in a research project (Mezuk et al. 2008;
Kettis-Lindblad et al. 2007). An important question with
respect to a commercial setting, however, is whether
customers are fully aware that they are participating in
research. Based on a recent analysis of websites from five
companies offering genome-wide testing directly to con-
sumers, there is little evidence that the participation of
customers in research is fully informed (Howard et al.
2010). As for the other three themes identified through
users’ personal stories: genealogy, curiosity/fascination, and
recreation, these also overlap with reasons given by
interviewees in McGowan’s study (McGowan et al. 2010).
(However, the authors did not discuss all these reasons in
their present article, explaining that these reasons “fell
outside the scope of” their analysis.) One motivation to
purchase GWT identified through the latter’s semi-
structured interviews that was not identified as an important
theme through personal users’ stories is social networking
possibilities. In other respects, it is interesting to note that a
study of personal stories posted on non-company websites
and company websites identified many of the same
motivations, albeit without obtaining the same depth of
information, as did McGowan’s semi-structured interview
study. That being said, we realize that it is possible that the
interviewees in McGowan’s study are also the authors of
some of the stories we studied.
Foremost, our study provides concrete information
regarding what motivates customers to purchase or use
DTC genome-wide testing. However, there are some
limitations with regard to methodology and the generaliza-
tion of results that should be noted. Firstly, it must be
acknowledged that since we accessed users based on the
posting of their stories on blogs or company websites, their
views may not be representative of all other users who
purchased DTC GWT (but who did not post their stories).
Secondly, as many personal stories emanate from compa-
nies’ websites, it is not clear whether these narratives are
genuine stories of users or if they were constructed in
collaboration with companies in order to publish archetype
stories as part of public relations’ initiative. Moreover, even
if these are genuine users’ stories, it is expected that
companies would have screened the stories in some way.
Thirdly, as our research was focused on companies offering
genome-wide testing, the results are not necessarily
applicable to other types of DTC genetic testing companies,
which are selling, for example, single-gene or multiple-
gene tests. This is an important point because many DTC
genetic testing companies do not sell GWT, and issues
raised and conclusions made about the latter do not always
apply to the former. As far as the scope of this study is
concerned, it was focused on personal stories of customers
who underwent testing; it does not report information
regarding consumers who have not purchased tests.
Moreover, concerns or misgivings regarding DTC genetic
tests or genetic testing in general were not studied.
Finally, an important question for users remains unan-
swered: “why purchase a genetic test from a company instead
of obtaining it through the traditional health care (THC)
system?”Unfortunately, the answer to this question would not
be informative with regard to genome-wide testing as this
service is not (yet) offered via the THC system. As for
companies offering single-gene or multiple-gene testing, they
have largely been neglected in (academic) studies and debates.
Therefore, all studies up until now which have focused on
DTC personal genome services are really asking “why do you
want to have hundreds of thousands or millions of genetic
markers tested?” The “direct-to-consumer” aspect is some-
what secondary since there is no real alternative source to
obtain these services. This has caused some confusion because
it is not the same as asking users why they opted for the
commercial offer of a test they could have obtained via the
THC system (i.e., BRCA1 testing). This question, however, is
important if the THC system aims to offer quality (and by
default, useful) genetic testing for the public. Here, the notion
of genetic testing as a consumer product or a health care
service becomes paramount.
Conclusions
Little is known about the motivational factors that stimulate
individuals to use DTC genome-wide testing. This article is
only the second study focused on studying actual users’
perspectives; we reported five major sets of motivations
relating to health, curiosity/fascination, genealogy, contribut-
ing to research, and recreation. The exploratory character and
results of this study show the need for further research in order
to better understand users’ motivations to use DTC genome-
wide testing and DTC genetics tests in general. Further studies
should include the understanding of users with respect to the
material on company websites as well as the character and
nature of this information (i.e., is it based on scientific
references, misleading, promotional, confusing?). Further
attention should also be paid to how users’ motivation may
change with time, how it may be related to specific disease
experiences, and other educational/professional, familial,
interpersonal, and social factors. Such information may help
us understand how users help shape the commercial market of
DTC GT and more importantly, if such testing is truly helpful
in improving their health status. Although it can be a difficult
task to obtain meaningful public feedback, it is a crucial task.
Knowing what the public wants is important, especially for
commercial endeavors, but knowing what the public needs to
improve their health can be a completely different question. If
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offering genomic information to improve health is truly our
goal, then we must make certain not confuse the two issues.
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